Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Clinical Endocrinology and Metabolism
Journal
Overview
Identity
Overview
Publication Venue For
Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States
. 108:706-712.
2023
Pharmacologic Weight Management in the Era of Adolescent Obesity
. 107:2716-2728.
2022
Changes in Type 2 Diabetes Trends in Children and Adolescents During the COVID-19 Pandemic
. 107:E2777-E2782.
2022
C-reactive Protein and Racial Differences in Type 2 Diabetes Incidence: The REGARDS Study
. 107:E2523-E2531.
2022
Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India
. 107:E2267-E2275.
2022
PCOS and Mendelian Randomization: Too Soon?
. 107:E2195-E2196.
2022
New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications.
. 107:e1339-e1347.
2022
Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance
. 107:E912-E923.
2022
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences
. 107:575-585.
2022
Insulin Resistance and Cardiometabolic Risk Profile among Nondiabetic American Young Adults: Insights from NHANES
. 107:E25-E37.
2022
Case Studies in Pediatric Lipid Disorders and Their Management
. 106:3605-3620.
2021
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients without Diabetes
. 106:E4360-E4371.
2021
Proinsulin to C-Peptide Ratio in the First Year after Diagnosis of Type 1 Diabetes
. 106:E4318-E4326.
2021
Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort
. 106:E3483-E3494.
2021
The Association of Lactation Duration with Visceral and Pericardial Fat Volumes in Parous Women: The CARDIA Study
. 106:1821-1831.
2021
Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS
. 106:E2151-E2161.
2021
Long-term change in physiological markers and cognitive performance in type 2 diabetes: The look ahead study
. 105.
2020
Race, ancestry, and Vitamin D metabolism: The multi-ethnic study of atherosclerosis
. 105.
2020
Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction
. 105.
2020
Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.
. 105:e3400-e3414.
2020
Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations"
. 105.
2020
Adipocyte insulin resistance in PCOS: Relationship with GLUT-4 expression and whole-body glucose disposal and β-cell function
. 105.
2020
Biomarkers and noncalcified coronary artery plaque progression in older men treated with testosterone
. 105.
2020
Prostate-Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial
. 104:6238-6246.
2019
Improving Long-Term Outcomes of Youth with Lipid Abnormalities - Expanding the Role of Pediatric Endocrinologists
. 104:4421-4426.
2019
JC viruria is associated with reduced risk of diabetic kidney disease
. 104:2286-2294.
2019
Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee
. 104:2875-2891.
2019
The effect of testosterone on cardiovascular biomarkers in the testosterone trials
. 103:681-688.
2018
ACTIVExtend: 24 Months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
. 103:2949-2957.
2018
Letter to the Editor: “Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis”
. 102:3865-3866.
2017
The relationship between the score on a simple measure of cognitive function and incident CVD in people with diabetes: A post hoc epidemiological analysis from the accord-mind study
. 102:3218-3225.
2017
No increase in fractures after stopping hormone therapy: Results from the women's health initiative
. 102:302-308.
2017
Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?
. 102:4421-4427.
2017
Triglyceride levels and fracture risk in midlife women: Study of women's health across the nation (SWAN)
. 101:3297-3305.
2016
Testosterone treatment and sexual function in older men with low testosterone levels
. 101:3096-3104.
2016
Erratum: Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and B cell function in overweight adults (J Clin Endocrinol (2013) 98:7 (E1173-E1180) doi: 10.1210/jc.2013-1203)
. 101:2265.
2016
Vitamin D supplementation modulates t cell-mediated immunity in humans: Results from a randomized control trial
. 101:533-538.
2016
Bone mineral density as a predictor of subsequent wrist fractures: Findings from the women's health initiative study
. 100:4315-4324.
2015
Impact of phosphorus-based food additives on bone and mineral metabolism
. 100:4264-4271.
2015
Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes
. 100:3871-3877.
2015
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials
. 100:1146-1155.
2015
Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al
. 100.
2015
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals
. 100:E182-E186.
2015
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome
. 99:E2754-E2761.
2014
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)
. 99:817-826.
2014
Insulin resistance indices are inversely associated with vitamin D binding protein concentrations
. 99:178-183.
2014
Polycystic ovary syndrome: What's in a name?
. 99:1142-1145.
2014
α-Internexin: A novel biomarker for pancreatic neuroendocrine tumor aggressiveness
. 99.
2014
The severity of menstrual dysfunction as a predictor of insulin resistance in pcos
. 98.
2013
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome
. 98.
2013
Hypercortisolism is associated with increased coronary arterial atherosclerosis: Analysis of noninvasive coronary angiography using multidetector computerized tomography
. 98:2045-2052.
2013
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females
. 98:1541-1548.
2013
Update on treatment strategies for obesity
. 98:1299-1306.
2013
20S-hydroxyvitamin D
3
, noncalcemic product of CYP11A1 action on vitamin D
3
, exhibits potent antifibrogenic activity in vivo
. 98.
2013
Associations of Total and Undercarboxylated Osteocalcin with Peripheral and Hepatic Insulin Sensitivity and β-Cell Function in Overweight Adults
. 98.
2013
Serum 25-hydroxyvitamin D response to vitamin D
3
supplementation 50,000 IU monthly in youth with HIV-1 infection
. 97:4004-4013.
2012
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility
. 97.
2012
Skeletal muscle lipid peroxidation and insulin resistance in humans
. 97.
2012
Association of intact parathyroid hormone levels with subsequent hip BMD loss: The Osteoporotic Fractures in Men (MrOS) study
. 97:1937-1944.
2012
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome
. 97.
2012
Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: Implications for progesterone actions in human pregnancy and parturition
. 97.
2012
Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: The CARDIA study
. 97:1337-1346.
2012
Adolescent diet and metabolic syndrome in young women: Results of the Dietary Intervention Study in Children (DISC) follow-up study
. 96.
2011
Smad2: A candidate gene for the murine autoimmune diabetes locus Idd21.1
. 96.
2011
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjögren's syndrome
. 96:3302-3307.
2011
Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies
. 96:3242-3249.
2011
Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with β-cell function
. 96.
2011
Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
. 96:E1142-E1147.
2011
Adiposity, inflammation, and risk for death in black and white men and women in the United States: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study
. 96:1805-1814.
2011
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome
. 96.
2011
Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome
. 96.
2011
Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered β-cell function
. 96.
2011
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160))
. 95:5137.
2010
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline
. 95:4133-4160.
2010
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
. 95:4985-4992.
2010
Postmenopausal hormone therapy: An endocrine society scientific statement
. 95:s1-s66.
2010
Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The "coronary artery risk development in young adults" women's study
. 95:4424-4431.
2010
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-α
. 95:935-942.
2010
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
. 95:4625-4634.
2010
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study
. 95:4432-4440.
2010
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome
. 94:3282-3288.
2009
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using
41
Ca methodology
. 94:3798-3805.
2009
Effect of dietary adherence with or without exercise on weight loss: A mechanistic approach to a global problem
. 94:1602-1607.
2009
Homocysteine levels and risk of hip Fracture in postmenopausal women
. 94:1207-1213.
2009
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia
. 94:17-20.
2009
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase gene
. 94:5034-5038.
2009
Loss of rap1GAP in papillary thyroid cancer
. 94:1026-1032.
2009
Neuropsychological features in primary hyperparathyroidism: A prospective study
. 94:1951-1958.
2009
Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates
. 94:1097-1103.
2009
Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men
. 94:2773-2780.
2009
Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents
. 94:3200-3206.
2009
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: Comparative efficacy of ergocalciferol, cholecalciferol, and UV light
. 94:2037-2043.
2009
Vitamin D deficiency in older men
. 94:1214-1222.
2009
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome
. 93:2909-2912.
2008
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome
. 93:1939-1945.
2008
Associations among insulin, estrogen, and fat mass gain over the pubertal transition in African-American and european-american girls
. 93:2610-2615.
2008
Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women
. 93:1796-1803.
2008
Changes over 14 years in androgenicity and body mass index in a biracial cohort of reproductive-age women
. 93:2158-2165.
2008
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
. 93:3785-3793.
2008
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage
. 93:809-814.
2008
Impact of obesity on the risk for polycystic ovary syndrome
. 93:162-168.
2008
Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents
. 93:4917-4923.
2008
Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome
. 93:300-303.
2008
Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects (Journal of Clinical Endocrinology and Metabolism 92, (1814-1820))
. 93:1082.
2008
Polycystic ovary syndrome is a family affair
. 93:1579-1581.
2008
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation
. 93:1276-1284.
2008
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease
. 93:4268-4275.
2008
Relationship of fat distribution with adipokines in human immunodeficiency virus infection
. 93:216-224.
2008
Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies
. 93:1062-1071.
2008
Thyroid hormones directly alter human hair follicle functions: Anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation
. 93:4381-4388.
2008
Analysis of the Fc receptor-like-3 (FCRL3) locus in caucasians with autoimmune disorders suggests a complex pattern of disease association
. 92:1106-1111.
2007
Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white women
. 92:4730-4733.
2007
Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation
. 92:1909-1919.
2007
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome
. 92:2659-2664.
2007
Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects
. 92:1814-1820.
2007
Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement
. 92:405-413.
2007
Soy isoflavones do not affect bone resorption in postmenopausal women: A dose-response study using a novel approach with
41
Ca
. 92:577-582.
2007
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years
. 91:2631-2637.
2006
Phytoestrogens and lipoproteins in women
. 91:2209-2213.
2006
A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor
. 91:1526-1534.
2006
Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism
. 91:1345-1350.
2006
Editorial: Uncoupling protein 3 and human metabolism
. 91:1226-1228.
2006
Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature
. 91:781-785.
2006
Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline
. 91:4237-4245.
2006
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
. 91:48-53.
2006
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
. 91:3451-3456.
2006
Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women
. 91:4085-4091.
2006
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study
. 90:6072-6076.
2005
Erratum: Effects of Aging on Cytochrome B5 Expression in the Human Adrenal Gland (The Journal of Clinical Endocrinology and Metabolism (2005) 90 (4357-4361))
. 90:5286.
2005
Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes
. 90:4920-4923.
2005
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span
. 90:4650-4658.
2005
Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndrome
. 90:4852-4857.
2005
Effects of aging on cytochrome B5 expression in the human adrenal gland
. 90:4357-4361.
2005
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling
. 90:4350-4356.
2005
Voluntary weight reduction in older men increases hip bone loss: The osteoporotic fractures in men study
. 90:1998-2004.
2005
Association of the intestinal fatty acid-binding protein Ala
54
Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women
. 90:1196-1201.
2005
Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: Clinical characterization and exclusion of candidate loci
. 90:4025-4034.
2005
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome
. 90:66-71.
2005
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome
. 89:5558-5562.
2004
Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach
. 89:4197-4205.
2004
The prevalence and features of the polycystic ovary syndrome in an unselected population
. 89:2745-2749.
2004
Hormones & you: patient information page. Hormones and obesity.
. 89.
2004
Androgen Excess in Women: Experience with over 1000 Consecutive Patients
. 89:453-462.
2004
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
. 88:5137-5144.
2003
Relationship between serum leptin concentration and low-density muscle in postmenopausal women
. 88:1157-1161.
2003
Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children
. 88:192-195.
2003
Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling
. 87:4085-4087.
2002
Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children.
. 87:2218-2224.
2002
Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children
. 87:2218-2224.
2002
Troglitazone use in polycystic ovary syndrome [4]
. 86:5090-5091.
2001
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
. 86:5450-5456.
2001
Longitudinal changes in body fat in African American and Caucasian children: Influence of fasting insulin and insulin sensitivity
. 86:3182-3187.
2001
Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropin
. 86:2513-2517.
2001
Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.
. 86:2513-2517.
2001
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
. 86:1626-1632.
2001
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
. 86:1626-1632.
2001
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: Implications regarding defects in vesicle trafficking
. 86:5450-5456.
2001
Weight loss is not associated hyperleptinemia in humans pancreatic cancer
. 86:162-166.
2001
Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women
. 85:4476-4480.
2000
Comment on extrapituitary parasellar macroadenoma in cushing's disease [1]
. 85:2082.
2000
Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women
. 85:48-54.
2000
Leptin in postmenopausal women: Influence of hormone therapy, insulin, and fat distribution
. 85:1770-1775.
2000
The skin produces urocortin
. 85:815-823.
2000
Comment on extrapituitary parasellar macroadenoma in Cushing's disease.
. 85:2082.
2000
Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
. 85:1770-1775.
2000
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin
. 85:3582-3588.
2000
Impact of architectural disruption on adrenocortical steroidogenesis in vitro.
. 84:1017-1021.
1999
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
. 84:946-950.
1999
Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans
. 84:3579-3585.
1999
Hypertension in women
. 84:1862-1866.
1999
Impact of architectural disruption on adrenocortical steroidogenesis in vitro
. 84:1017-1021.
1999
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level
. 84:946-950.
1999
Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis
. 83:2317-2323.
1998
Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study
. 83:3078-3082.
1998
Characterization of corticotropin-releasing hormone (CRH) in human skin
. 83:1020-1024.
1998
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)
. 83:1976-1987.
1998
The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women
. 83:519-524.
1998
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
. 83:3078-3082.
1998
Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
. 83:2317-2323.
1998
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).
. 83:1976-1987.
1998
Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy
. 83:3219-3224.
1998
Serum leptin and energy expenditure in children.
. 82:4149-4153.
1997
Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children
. 82:2148-2152.
1997
Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children.
. 82:2148-2152.
1997
The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure
. 82:1293-1300.
1997
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.
. 82:1293-1300.
1997
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism
. 82:479-485.
1997
Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate
. 82:465-472.
1997
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
. 82:479-485.
1997
Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate.
. 82:465-472.
1997
Aging alters zonation in the adrenal cortex of men
. 82:3898-3901.
1997
Serum leptin and energy expenditure in children
. 82:4149-4153.
1997
Role of the β
3
-adrenergic receptor locus in obesity and noninsulin- dependent diabetes among members of Caucasian families with a diabetic sibling pair
. 81:4422-4427.
1996
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin
. 81:2746-2749.
1996
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin.
. 81:2746-2749.
1996
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles.
. 80:2437-2446.
1995
Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells.
. 80:1027-1031.
1995
Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation
. 80:400-405.
1995
Erratum: Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells (Journal of Clinical Endocrinology and Metabolism (1995) 80 (1027-1031))
. 80:1971.
1995
Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children
. 80:172-178.
1995
Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells
. 80:1027-1031.
1995
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study
. 80:3406-3411.
1995
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles
. 80:2437-2446.
1995
Clinical review 56: nonclassic adrenal hyperplasia: Current concepts
. 78:810-815.
1994
Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues
. 78:234-236.
1994
Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women
. 79:1747-1751.
1994
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles.
. 77:286-289.
1993
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles
. 77:286-289.
1993
Adrenocorticotropin interferes with transforming growth factor-β-induced growth inhibition of neocortical cells from the human fetal adrenal gland
. 75:1519-1521.
1992
Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation
. 73:1327-1331.
1991
The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women
. 72:1025-1030.
1991
Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling time
. 70:1273-1279.
1990
Changes in Endocrine Function after Adrenal Medullary Transplantation to the Central Nervous System
. 71:773-776.
1990
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism
. 70:431-436.
1990
21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and Diagnosis
. 69:577-584.
1989
CV 205–502 treatment of hyperprolactinemia
. 68:336-339.
1989
Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary
. 66:804-810.
1988
The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1.
. 65:1098-1101.
1987
In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-Deficient individuals
. 64:98-105.
1987
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study
. 60:698-705.
1985
Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus
. 60:559-568.
1985
Thyrotropin (TSH)-induced hyperthyroidism: Response of TSH to dopamine and its agonists
. 58:255-261.
1984
Umbilical Cord Plasma Levels of Dehydroepiandrosterone Sulfate during Human Gestation
. 54:1216-1220.
1982
Diurnal patterns and regulation of cortisol secretion in pregnancy
. 51:466-472.
1980
Plasma angiotensin converting enzyme activity in mother and fetus
. 46:434-439.
1978
Effects of ph and enzyme inhibitors on apparent generation of angiotensin i in human plasma
. 39:965-968.
1974
Identity
International Standard Serial Number (issn)
0021-972X
Electronic International Standard Serial Number (eissn)
0021-972X
1945-7197